Consumer Product Safety Commission
Pfizer has recalled 4.2 million packages of 75mg Nurtec ODT (orally disintegrating tablets).
Used to treat migraines in adults, the recall was issued because it did not meet child-safe packaging requirements, posing a harmful risk when consumed by young children.
of Consumer Product Safety Commission It was reported today that the recall involves a package containing one sheet of eight tablets, all with an expiration date of June 2026.
according to Pfizer websitethey have “identified no adverse events or safety concerns related to this child-safe packaging issue.”
Luggage must be secured immediately out of reach of children.consumers can Contact Pfizer Free childproof replacement package.
Pfizer said patients can continue to take their medication as prescribed. The pharmacist fills future orders by placing the pills in child-safe vials with lids.
“Patients will continue to have access to Nurtec ODT through their pharmacy,” the company said in a statement. “This notice relates to the packaging of Nurtec ODT and does not change the drug’s established safety profile when formulated for its intended use.”
